Curated News
By: NewsRamp Editorial Staff
February 10, 2025
Quantum BioPharma Retains PR Firms for Investor Awareness, Highlights Key Product Progress
Discuss on Reddit
LinkedIn
Substack
Telegram
GithubTLDR
- Quantum BioPharma (NASDAQ: QNTM) enhances investor awareness with strategic public relations partnerships.
- Enterprise Canada Inc. and Empire Market Ventures, LLC lead Quantum BioPharma's media strategy and investor marketing.
- Quantum BioPharma's innovations aim to treat neurodegenerative disorders, alcohol misuse, and multiple sclerosis, improving quality of life.
- Unbuzzd, a rapid alcohol detox drink, and other key products by Quantum BioPharma offer promising solutions for various health conditions.
Impact - Why it Matters
This news highlights Quantum BioPharma's strategic approach to enhancing its public relations and investor relations efforts. Investors and stakeholders can stay informed about the company's key products and advancements in the biopharmaceutical industry. It underscores Quantum BioPharma's commitment to developing innovative solutions for challenging disorders.
Summary
Quantum BioPharma (NASDAQ: QNTM) has retained Enterprise Canada Inc. and Empire Market Ventures, LLC to lead its public relations and investor awareness efforts. Enterprise will focus on the company’s media strategy, while Empire will handle investor marketing and outreach. The company highlighted progress on key products, including unbuzzd, a rapid alcohol detoxification beverage, rekvry for alcohol misuse treatment, and LUCID-21-302 for multiple sclerosis.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Quantum BioPharma Retains PR Firms for Investor Awareness, Highlights Key Product Progress
